Curaleaf (OTCMKTS:CURLF) Trading 11.4% Higher – Time to Buy?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) rose 11.4% during mid-day trading on Tuesday . The company traded as high as $2.46 and last traded at $2.45. Approximately 225,577 shares changed hands during trading, a decline of 60% from the average daily volume of 566,712 shares. The stock had previously closed at $2.20.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Alliance Global Partners reissued a “buy” rating on shares of Curaleaf in a research report on Monday, December 22nd. ATB Cormark Capital Markets upgraded Curaleaf to an “outperform” rating in a research report on Tuesday, December 2nd. Finally, Zacks Research raised Curaleaf from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy”.

Get Our Latest Research Report on CURLF

Curaleaf Stock Performance

The company has a market capitalization of $1.69 billion, a P/E ratio of -7.78 and a beta of 0.74. The stock has a fifty day simple moving average of $2.61 and a 200-day simple moving average of $2.70. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.96.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.

Featured Stories

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.